About
NanoEnTek, Inc. is a South Korean biotechnology company founded in 1987 and listed on the KOSDAQ stock exchange since 2006. The company specializes in developing and producing innovative life science research tools and in-vitro diagnostic (IVD) medical devices, utilizing advanced Bio-MEMS and microfluidic "lab-on-a-chip" technology. Their product portfolio includes automated cell counters, live-cell imaging systems, and rapid immunoassay analyzers. Notable products are the Countess automated cell counter, which captures a significant market share, and the FREND System, a rapid quantitative immunoassay analyzer designed for point-of-care testing. NanoEnTek holds around 100 patents in nanotechnology, information technology, and biotechnology, emphasizing its commitment to innovation. The company has also received US FDA approval for six products, enhancing its international market presence. Headquartered in Seoul, NanoEnTek employs over 100 experts across various fields, focusing on improving efficiency and accuracy in life science research and diagnostics. Their mission is to share technological innovations globally to advance health and scientific discovery.
Technologies
Keywords
Company Information
-
Employees 81
-
Founded 2000
-
Annual Revenue $8000000
Location
Seoul, South Korea, 152-050
